Description

 

  • As monotherapy in the treatment of partial onset seizures, with or without secondary generalization, in adults (16 years and older).
  • Ad adjunctive therapy in the treatment of partial onset seizures, with or without secondary generalization, in adults, adolescents and children one month of age and older with epilepsy.